GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Covetrus Inc (NAS:CVET) » Definitions » Shares Buyback Ratio %

Covetrus (Covetrus) Shares Buyback Ratio % : -1.80 (As of May. 07, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Covetrus Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Covetrus's current shares buyback ratio was -1.80%.

Covetrus Shares Buyback Ratio % Historical Data

The historical data trend for Covetrus's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covetrus Shares Buyback Ratio % Chart

Covetrus Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shares Buyback Ratio %
Get a 7-Day Free Trial - - -0.38 -21.86 -1.47

Covetrus Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.75 -0.27 -0.20 -0.82 -0.50

Covetrus Shares Buyback Ratio % Calculation

Covetrus's Shares Buyback Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2020 ) - Shares Outstanding (EOP) (A: Dec. 2021 )) / Shares Outstanding (EOP) (A: Dec. 2020 )
=(136.018 - 138.012) / 136.018
=-1.47%

Covetrus's Shares Buyback Ratio for the quarter that ended in Jun. 2022 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2022 ) - Shares Outstanding (EOP) (A: Jun. 2022 )) / Shares Outstanding (EOP) (A: Mar. 2022 )
=(139.143 - 139.839) / 139.143
=-0.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covetrus Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Covetrus's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Covetrus (Covetrus) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Covetrus Inc (NAS:CVET) » Definitions » Shares Buyback Ratio %
Comparable Companies
PBH PDCO OMI ZYXI GEG HSIC MCK ABC CAH SHSE:601607 HKSE:01099 HAM:CLS1 NZSE:EBO XSWX:GALE SHSE:600056 SHSE:600739 TSE:7459 TSE:2784 XKRX:008930 TSE:9987
Traded in Other Exchanges
N/A
Address
7 Custom House Street, Portland, ME, USA, 04101
Website
https://www.covetrus.com
Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe and the Asia Pacific (APAC) and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management.
Executives
Benjamin Wolin director C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Edward Mcnamara director C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Rebecca Ann Kidd officer: Head of Global Operations 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Matthew Malenfant officer: Chief Commercial Officer 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Andrew B. Coxhead officer: See Remarks C/O RR DONNELLEY, 111 SOUTH WACKER DRIVE, CHICAGO IL 60606
Dustin Finer officer: Chief People Officer 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Paul R. Fonteyne director C/O RESTORBIO, INC., 501 BOYLSTON STREET SUITE 6102, BOSTON MA 02116
Laura J Phillips officer: See Remarks 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Michael Ellis officer: See Remarks C/O HS SPINCO, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Timothy Ludlow officer: See Remarks C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Georgina Wraight officer: See Remarks C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
David Stuart Hinton officer: See Remarks C/O HS SPINCO, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Providenti Anthony C. Jr. officer: See Remarks 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jamey S Seely officer: General Counsel and Secretary C/O GATES INDUSTRIAL CORPORATION PLC, 1144 FIFTEENTH STREET, SUITE 1400, DENVER CO 80202
Sandra E Peterson director 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417